Astrana Health Inc reports results for the quarter ended in January - Earnings Summary
08/08/2024 02:50
* Astrana Health Inc ASTH.OQ reported quarterly adjusted
earnings of 40 cents per share for the quarter ended in
January, higher than the same quarter last year, when the
company reported EPS of 28 cents. The mean expectation of
eight analysts for the quarter was for earnings of 39 cents per
share. Wall Street expected results to range from 32 cents to 43
cents per share.
* Revenue rose 39.6% to $486.27 million from a year ago;
analysts
expected $440.75 million.
* Astrana Health Inc's reported EPS for the quarter was 40
cents.
* The company reported quarterly net income of $19.17
million.
* Astrana Health Inc shares had risen by 17.3% this
quarter and
gained 24.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 8.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "strong buy"
Wall Street's median 12-month price target for Astrana Health
Inc is $57.50
This summary was machine generated from LSEG data August 8 at
01:49 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.39 0.40 Beat
Mar. 31 2024 0.30 0.31 Beat
Dec. 31 2023 0.15 0.26 Beat
Sep. 30 2023 0.33 0.47 Beat